Sage Journals: Discover world-class research

Retricted access

Case report

First published 2023-5

Two cases of drug induced hypersensitivity to dolutegravir-rilpivirine fixed-dose combination: A case report

Giovanni Del Fabro, Palmiro Mileto, Francesco Castelli [...]

International Journal of Risk & Safety in Medicine

Free access

Announcement

First published 2019-1

A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients

Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti [...]

Antiviral Therapy

Open access

Research article

First published 2022-2

Dolutegravir/rilpivirine 2-drug regimen comparable to commonly prescribed 3-drug regimens up to 18-months in a real-world setting

Gerald Pierone, Jennifer S Fusco, Vani Vannappagari [...]

Antiviral Therapy

Retricted access

Research article

First published 2018-1

Effectiveness,Safety,and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

José Luis Revuelta-Herrero, Esther Chamorro-de-Vega, Carmen Guadalupe Rodríguez-González [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2018-12

Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database

Ricky Hsu, Jennifer Fusco, Cassidy Henegar [...]

Therapeutic Advances in Drug Safety

Retricted access

Research article

First published 2022-4

Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid

Miguel Ángel Amor-García, Carmen Guadalupe Rodríguez-González, Esther Chamorro-de-Vega [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2019-8

Dolutegravir-Rilpivirine,Dual Antiretroviral Therapy for the Treatment of HIV-1 Infection

E. Kelly Hester, Kevin Astle

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-06

Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

Marta Ruiz-Algueró, Belén Alejos, Cristina García Yubero [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2018-8

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data

Amedeo Ferdinando Capetti, Maria Vittoria Cossu, Gaetana Sterrantino [...]

Annals of Pharmacotherapy

Open access

Brief report

First published 2018

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

Rosario Palacios, M. Mayorga, C. M. González-Domenech [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Search results